AU2002213422A1 - Synthesis of 2-hydroxymethylglutamic acid and congeners thereof - Google Patents
Synthesis of 2-hydroxymethylglutamic acid and congeners thereofInfo
- Publication number
- AU2002213422A1 AU2002213422A1 AU2002213422A AU1342202A AU2002213422A1 AU 2002213422 A1 AU2002213422 A1 AU 2002213422A1 AU 2002213422 A AU2002213422 A AU 2002213422A AU 1342202 A AU1342202 A AU 1342202A AU 2002213422 A1 AU2002213422 A1 AU 2002213422A1
- Authority
- AU
- Australia
- Prior art keywords
- hydroxymethylglutamic
- congeners
- synthesis
- acid
- hydroxymethylglutamic acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- UCEVIADUYUFCFO-ZCFIWIBFSA-N (2r)-2-amino-2-(hydroxymethyl)pentanedioic acid Chemical compound OC[C@@](N)(C(O)=O)CCC(O)=O UCEVIADUYUFCFO-ZCFIWIBFSA-N 0.000 title 1
- 230000015572 biosynthetic process Effects 0.000 title 1
- 239000000039 congener Substances 0.000 title 1
- 238000003786 synthesis reaction Methods 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C229/24—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having more than one carboxyl group bound to the carbon skeleton, e.g. aspartic acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/04—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D263/06—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by oxygen atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/07—Optical isomers
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US23227500P | 2000-09-13 | 2000-09-13 | |
| US60/232,275 | 2000-09-13 | ||
| PCT/US2001/042181 WO2002022622A2 (en) | 2000-09-13 | 2001-09-13 | Synthesis of 2-hydroxymethylglutamic acid and congeners thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2002213422A1 true AU2002213422A1 (en) | 2002-03-26 |
Family
ID=22872492
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2002213422A Abandoned AU2002213422A1 (en) | 2000-09-13 | 2001-09-13 | Synthesis of 2-hydroxymethylglutamic acid and congeners thereof |
Country Status (3)
| Country | Link |
|---|---|
| US (1) | US6599940B2 (en) |
| AU (1) | AU2002213422A1 (en) |
| WO (1) | WO2002022622A2 (en) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR059898A1 (en) * | 2006-03-15 | 2008-05-07 | Janssen Pharmaceutica Nv | DERIVATIVES OF 3-CIANO-PIRIDONA 1,4-DISUSTITUTED AND ITS USE AS ALLOSTERIC MODULATORS OF MGLUR2 RECEIVERS |
| TW200900065A (en) | 2007-03-07 | 2009-01-01 | Janssen Pharmaceutica Nv | 3-cyano-4-(4-pyridinyloxy-phenyl)-pyridin-2-one derivatives |
| TW200845978A (en) | 2007-03-07 | 2008-12-01 | Janssen Pharmaceutica Nv | 3-cyano-4-(4-tetrahydropyran-phenyl)-pyridin-2-one derivatives |
| AU2008297877C1 (en) * | 2007-09-14 | 2013-11-07 | Addex Pharma S.A. | 1,3-disubstituted-4-phenyl-1 H-pyridin-2-ones |
| KR20100065191A (en) | 2007-09-14 | 2010-06-15 | 오르토-맥닐-얀센 파마슈티칼스 인코포레이티드 | 1,3-disubstituted 4-(aryl-x-phenyl)-1h-pyridin-2-ones |
| DE602008004794D1 (en) | 2007-09-14 | 2011-03-10 | Addex Pharmaceuticals Sa | 1 ', 3'-DISUBSTITUTED 4-PHENYL-3,4,5,6-TETRAHYDRO-2H, 1'H-Ä1,4'-UPBIPYRIDINYL-2'-ONE |
| US8785486B2 (en) | 2007-11-14 | 2014-07-22 | Janssen Pharmaceuticals, Inc. | Imidazo[1,2-A]pyridine derivatives and their use as positive allosteric modulators of mGluR2 receptors |
| EP2344470B1 (en) | 2008-09-02 | 2013-11-06 | Janssen Pharmaceuticals, Inc. | 3-azabicyclo[3.1.0]hexyl derivatives as modulators of metabotropic glutamate receptors |
| CN102186477B (en) | 2008-10-16 | 2013-07-17 | 奥梅-杨森制药有限公司 | Indole and benzomorpholine derivatives as modulators of metabotropic glutamate receptors |
| CN102232074B (en) | 2008-11-28 | 2014-12-03 | 奥梅-杨森制药有限公司 | Indole and benzoxazine derivatives as modulators of metabotropic glutamate receptors |
| MY153913A (en) | 2009-05-12 | 2015-04-15 | Janssen Pharmaceuticals Inc | 7-aryl-1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors |
| AR076861A1 (en) | 2009-05-12 | 2011-07-13 | Addex Pharma Sa | DERIVATIVES OF 1,2,4-TRIAZOLO (4,3-A) PIRIDINE AND ITS USE AS POSITIVE ALOSTERIC MODULATORS OF MGLUR2 RECEIVERS |
| WO2010130422A1 (en) | 2009-05-12 | 2010-11-18 | Ortho-Mcneil-Janssen Pharmaceuticals, Inc | 1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors |
| CA2814998C (en) | 2010-11-08 | 2019-10-29 | Janssen Pharmaceuticals, Inc. | 1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors |
| US8993591B2 (en) | 2010-11-08 | 2015-03-31 | Janssen Pharmaceuticals, Inc. | 1,2,4-triazolo[4,3-a] pyridine derivatives and their use as positive allosteric modulators of MGLUR2 receptors |
| ES2552455T3 (en) | 2010-11-08 | 2015-11-30 | Janssen Pharmaceuticals, Inc. | 1,2,4-Triazolo [4,3-a] pyridine derivatives and their use as positive allosteric modulators of mGluR2 receptors |
| JO3368B1 (en) | 2013-06-04 | 2019-03-13 | Janssen Pharmaceutica Nv | 6, 7- dihydropyrazolu [5,1-a] pyrazine-4 (5 hands) -on compounds and their use as negative excretory regulators of Miglore 2 receptors. |
| JO3367B1 (en) | 2013-09-06 | 2019-03-13 | Janssen Pharmaceutica Nv | 1,2,4-TRIAZOLO[4,3-a]PYRIDINE COMPOUNDS AND THEIR USE AS POSITIVE ALLOSTERIC MODULATORS OF MGLUR2 RECEPTORS |
| PH12019500127B1 (en) | 2014-01-21 | 2022-05-04 | Janssen Pharmaceutica Nv | Combinations comprising positive allosteric modulators or orthosteric agonists of metabotropic glutamatergic receptor subtype 2 and their use |
| SMT201900545T1 (en) | 2014-01-21 | 2019-11-13 | Janssen Pharmaceutica Nv | Combinations comprising positive allosteric modulators or orthosteric agonists of metabotropic glutamatergic receptor subtype 2 and their use |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3810973A1 (en) * | 1988-03-31 | 1989-10-12 | Bayer Ag | 1- (N-FORMYLAMINO) -2,4-DICYANOBUTANE AND A METHOD FOR THE PRODUCTION THEREOF |
| AU8534291A (en) | 1990-08-10 | 1992-03-02 | G.D. Searle & Co. | Renal-selective angiotensin ii antagonists for treatment of hypertension |
| US5190922A (en) | 1991-06-04 | 1993-03-02 | Abbott Laboratories | Terminally modified tri-, tetra- and pentapeptide anaphylatoxin receptor ligands |
| JPH0532697A (en) | 1991-07-31 | 1993-02-09 | Teijin Ltd | Synthetic human osteocalcin and method for producing the same |
| HU222776B1 (en) | 1992-05-20 | 2003-10-28 | Northwestern University | Intermediates for the preparation of (S) - (+) - 4-amino-3- (2-methylpropyl) butanoic acid, intermediates of the new hexanoic acid and butanedioic acid and their preparation |
| US5686565A (en) | 1992-10-08 | 1997-11-11 | Scios Inc. | Bradykinin antagonist pseudopeptide derivatives of aminoalkanoic acids and related olefins |
| US5362899A (en) | 1993-09-09 | 1994-11-08 | Affymax Technologies, N.V. | Chiral synthesis of alpha-aminophosponic acids |
| US5880096A (en) | 1994-02-02 | 1999-03-09 | Affymax Technologies N.V. | Peptides and compounds that bind to the IL-1 receptor |
| US5780589A (en) | 1994-11-30 | 1998-07-14 | The United States Of America As Represented By The Department Of Health And Human Services | Ultraselective opioidmimetic peptides and pharmacological and therapeutic uses thereof |
| US5744451A (en) | 1995-09-12 | 1998-04-28 | Warner-Lambert Company | N-substituted glutamic acid derivatives with interleukin-1 β converting enzyme inhibitory activity |
| US6200969B1 (en) | 1996-09-12 | 2001-03-13 | Idun Pharmaceuticals, Inc. | Inhibition of apoptosis using interleukin-1β-converting enzyme (ICE)/CED-3 family inhibitors |
| US6133409A (en) | 1996-12-19 | 2000-10-17 | Aventis Pharmaceuticals Products Inc. | Process for the solid phase synthesis of aldehyde, ketone, oxime, amine, hydroxamic acid and αβ-unsaturated carboxylic acid and aldehyde compounds |
| CA2276109C (en) | 1996-12-27 | 2003-11-18 | Boehringer Ingelheim (Canada) Ltd. | Peptidomimetic inhibitors of the human cytomegalovirus protease |
| US6133018A (en) | 1997-06-02 | 2000-10-17 | Celgro | Enzymatic synthesis of chiral amines using -2-amino propane as amine donor |
| US6242422B1 (en) | 1998-10-22 | 2001-06-05 | Idun Pharmacueticals, Inc. | (Substituted)Acyl dipeptidyl inhibitors of the ice/ced-3 family of cysteine proteases |
-
2001
- 2001-09-13 AU AU2002213422A patent/AU2002213422A1/en not_active Abandoned
- 2001-09-13 US US09/952,325 patent/US6599940B2/en not_active Expired - Fee Related
- 2001-09-13 WO PCT/US2001/042181 patent/WO2002022622A2/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| US20020147362A1 (en) | 2002-10-10 |
| WO2002022622A2 (en) | 2002-03-21 |
| US6599940B2 (en) | 2003-07-29 |
| WO2002022622A3 (en) | 2003-04-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2002213422A1 (en) | Synthesis of 2-hydroxymethylglutamic acid and congeners thereof | |
| AU2002213248A1 (en) | Synthesis of epothilones and relates analogs | |
| AU2002225855A1 (en) | Preparation of nanocrystallites | |
| AU2001291859A1 (en) | Use of copolycarbonates | |
| AU2002346548A1 (en) | Regioisomerically pure oxochlorins and methods of synthesis | |
| AU4670800A (en) | Novel compositions comprising trimetrexate and methods of their synthesis and use | |
| AU2001277278A1 (en) | Method and system of providing competitive comparative terms to the user | |
| AU2002256108A1 (en) | Synthesis and use of glycodendrimer reagents | |
| AU2001241539A1 (en) | Synthesis of resveratrol | |
| AU2001269685A1 (en) | Crystallization of 4-diphosphocytidyl-2-c-methylerythritol synthesis | |
| AU2001297611A1 (en) | Pharmaceutical uses and synthesis of diketopiperazines | |
| AU5587200A (en) | Synthesis of substituted amidines | |
| AU2002230781A1 (en) | Pharmaceutical uses and synthesis of benzobicyclooctanes | |
| AU2001265280A1 (en) | Preparation of 2-hydroxy-5-oxoproline and analogs thereof | |
| AU2001264863A1 (en) | Preparation of fagopyritols and uses therefor | |
| AU2002246926A1 (en) | 12-hydroxy-eicosatrienoic acid analogs and methods of use thereof | |
| AUPQ596600A0 (en) | Point of sale system | |
| AU2001274022A1 (en) | Use of substituted 1-amino-5-phenylpentane-3-ol and/or 1-amino-6-phenylhexane-3-ol compounds as medicaments | |
| AU4450100A (en) | 225Ac-heha and related compounds, methods of synthesis and methods of use | |
| AU2001257253A1 (en) | Asymmetric synthesis of piperazic acid and derivatives thereof | |
| AUPR197000A0 (en) | Synthesis of small particles | |
| AU2001255708A1 (en) | Synthesis and use of thienotriazolodiazepines | |
| AU1354201A (en) | Compositions and methods of synthesis and use of novel nucleic acid structures | |
| AU2001286032A1 (en) | Storage and conversion of compositions | |
| AU2580299A (en) | Synthesis of dysidiolide and uses thereof |